Simultaneous quantification of five bioactive phenylethanoid, iridoid, and flavonol glycosides in Duranta erecta L.: Ultra performance liquid chromatography method validation and uncertainty measurement

Validation of an HPLC-DAD Method for Quercetin Quantification in Nanoparticles

The evaluation of the efficacy of incorporation of quercetin in nanoparticles is crucial, both for the development and quality control of pharmaceutical formulations. The validation of analytical methods for the precise quantification of quercetin is useful for the evaluation of various potential quercetin delivery systems and quercetin pharmacokinetics. This work aimed to validate a high-performance liquid chromatography with diode array detection (HPLC-DAD) method for quercetin detection and quantification in nanoparticles. Different mobile phase conditions and detection wavelengths (254 and 368 nm) were tested, and the major validation parameters were assessed (precision, accuracy, linearity, sensitivity, stability, and selectivity). The best peak resolution was obtained when quercetin was analyzed at 368 nm with a mobile phase of 1.5% acetic acid and a water/acetonitrile/methanol ratio of 55:40:5. Under these conditions, quercetin also eluted rapidly (retention time of 3.6 min). The method proved to be linear (R2 > 0.995), specific, and repeatable (variation coefficient between 2.4% and 6.7%) and presented intermediate precision (variation coefficient between 7.2% and 9.4%). The accuracy of the analysis ranged between 88.6% and 110.7%, and detection and quantification limits were 0.046 and 0.14 µg/mL, respectively. Quercetin solutions were more stable when stored at 4 °C than at room temperature or -20 °C. This validated method satisfied more parameters of bias assessment than most recent methods for quercetin determination and presented itself as more sensitive and efficient than general spectrophotometric methods. The method was successfully used for the analysis of quercetin incorporation in nanoparticles and will be evaluated in the future for its adequacy for the determination of quercetin in more complex matrices.

Chromatographic Methods Developed for the Quantification of Quercetin Extracted from Natural Sources: Systematic Review of Published Studies from 2018 to 2022

Quercetin (QUE) is the most widely used flavonoid for therapeutic purposes. To improve the available knowledge about the properties of some natural products, determining the amount of QUE is crucial. The main objective of this systematic review is to identify the analytical methods validated for detecting and quantifying QUE in different matrices and characterize their sensitivity. A search was conducted until 30 June 2023 in the PubMed database for experimental studies that addressed the validation of chromatographic analytical methods to detect and quantify QUE from consumable natural products. Only studies published between 2018 and 2022, written in English, were included. The risk of bias was assessed by emphasizing methods of comparison according to previously published studies. Descriptive statistics were used to depict the obtained results. The studies were analyzed based on the type of QUE source, chromatographic method, and validation parameters. A total of 17 studies were included in this review. Plants were the most commonly analyzed source of QUE. Among the detection methods, spectrophotometry proved to be the most widely used, surpassing mass spectrometry (MS). After analyzing the bias, all the included studies mentioned/presented, totally or partially, at least four of the eight parameters.

Duranta erecta Linn: A critical review on phytochemistry, traditional uses, pharmacology, and toxicity from phytopharmaceutical perspective

ETHNOPHARMACOLOGICAL RELEVANCE

Duranta erecta Linn. belonging to the Verbenaceae family is widely used in the traditional systems of medicines practiced in Bangladesh, India, Nigeria, the Philippines, and Brazil. The ethnomedicinal application as vermifuge, febrifuge, diuretic, anti-parasitic, and anti-malarial are well documented. D. erecta is also a significant source of phenylethanoid glycoside known as acteoside-a drug in clinical trials for IgA nephropathy patients.

AIM OF THIS REVIEW

This review aims to critically highlight the existing studies on D. erecta, including its botanical authentication, geographical distribution, ethnomedicinal uses, phytochemistry, and pharmacological properties. Critical discussion is focused on the overview and gap in knowledge for future research. Additionally, the clinical significance of its major secondary metabolite, i.e., acteoside, has also been discussed with emphasis on biosynthesis, distribution, pre-clinical, and clinical outcomes.

MATERIALS AND METHODS

Professional research data from 1963 to 2021 appeared in scholarly journals, and books were retrieved from scientific database platforms viz. Sci-Finder, PubMed, CNKI, Science Direct, Web of Science, Wiley, Google Scholar, Taylor and Francis, Springer, and Scopus. The chemical structures for all the phytomolecules were validated using Sci-finder and first-hand references. While plant name and synonyms were corroborated by "The Plant List" (www.theplantlist.org).

RESULTS

D. erecta and its key metabolite acteoside display various biological actions like antimalarial, antimicrobial, antioxidant, anticancer, antinephritic, hepatoprotective, neuroprotective, and antiviral properties. Acteoside literature analysis shows its presence in different stages of clinical trials for anti-nephritic, hepatoprotective, and osteoarthritic activity. The phytochemical review of D. erecta exhibited 64 compounds that have been isolated and identified from D. erecta, such as iridoid glycosides, phenylethanoid glycosides, flavonoids, steroids, phenolics, terpenoids, and saponins. The other significant secondary metabolites responsible for its medicinal properties are acteoside, durantol, pectolinaringenin, repenins, scutellarein, and repennoside.

CONCLUSION

Duranta erecta is one of the Verbenaceae plants, widely used in ethnomedicines having various phytochemicals with understandable pharmacological actions mainly confined at the crude extract level. However, further bioactivity-guided or fingerprint-assisted studies are required to validate the ethnomedicinal uses, concerning cellular and molecular mechanisms, quality standardization, and safety with respect to its bioactive constituent(s). Therefore, the present review identified the gap in the research on scientific validation of Duranta based ethnomedicines and may provide critical information for the development of phytopharmaceuticals/Phyto-cosmeceuticals.

Isolation, optimized extraction, and ultra-high performance liquid chromatography with photodiode array method for quantitative analysis of chiratol in Swertia paniculata

The global natural product-based industry is growing fast with the introduction of new phytochemicals and herbal extract products from different geographical regions. Swertia paniculata is a well-known plant with medicinal properties; however, the quality control for its major phytochemical constituents from the Himalayan geographical region is nevertheless reported. Therefore, the first objective of this investigation was to characterize and optimize the extraction process while the second objective was to validate a quantitative analytical method for chiratol from S. paniculata herbal extract. The chiratol was characterized with spectral analysis. The optimum extraction condition for the highest yield of metabolite was realized in chloroform as a solvent system under ultrasonication. The ultra-high performance liquid chromatography coupled with photodiode array detection method for analytical quantification was validated for specificity, linearity, limits of detection, limits of quantification, precision, repeatability, recovery, and robustness using Eclipse Plus C18 column (100 mm × 4.6 mm × 3.5 μm id). The gradient elution of water/acetonitrile as mobile phase was used at a flow rate of 0.5 ml/min. The recovery percentage was very satisfactory with values within specification. The robustness parameters showed no substantial influence of evaluated parameters by the Youden test. The developed method was ascertained to be appropriate for the proposed purpose.

DETERMINATION OF TOTAL PHENOLIC CONTENT FROM PLANT EXTRACTS USED IN COSMETIC PURPOSE

Spectrometric analysis belongs to a group of measurement methods used for their simplicity and large selectivity to solve various problems of analytes. The total phenolic content of different plant extracts used for cosmetic purpose was determined by a slightly modified version of traditionally Folin-Ciocalteau method. The objective of this work was the validation of UV-Vis spectrometric method, investigation of uncertainty sources when measuring gallic acid concentration and evaluation of the calibration equation effect on measurement uncertainty of UV– Vis spectrophotometer. Validation was performed by studying analytical curve linearity (R2=0.9995) and range (37.5 – 225 mg L-1), estimated limit of detection (LOD, 0.11mg L-1) and limit of quantification (LOQ, 0.37 mg L-1), precision (%RSD, 0.14 – 1.34), recoveries (83-110%) and stability (%RSD, 0.8 – 2.83). To obtain more representative values for precision, recoveries and stability simultaneous replicates at different times, on different matrices including plant (marigold, chamomile and lavender) were performed during the study period. The validated method was successfully applied to determine TPC in marigold extracts. For chamomile and lavender extracts, the spectrometric method presented only acceptable precision, among all the performance parameters studied. The sources of the gallic acid concentration measurement uncertainty include purity, volume of flasks, mass and the calibration equation. The results indicated that the uncertainty components from purity were the smallest. An important source of the uncertainty was the mass.The volumes of the volumetric flasks had only modest effect on the uncertainty. The contribution of calibration equation is the greatest from all sources.

Antiviral Activity of Belladonna During Japanese Encephalitis Virus Infection via Inhibition of Microglia Activation and Inflammation Leading to Neuronal Cell Survival

Japanese encephalitis virus (JEV) is the main cause of viral encephalitis resulting in more than 68 000 clinical cases every year with case fatality rate as high as 30-40% for which no specific treatments are available. We have recently exhibited belladonna may be widely applicable for the treatment of various neurological disorders. Therefore, we developed a hydroalcoholic formulation of belladonna (B200) consisting of atropine and scopolamine and showed its antiviral efficacy against JEV infection. B200 treatment increases neuronal cell survival by reducing JEV induced cytopathic effects which were evident from significant reduction in necrotic cell population by flow-cytometry analysis and caspase 3 and 8 enzymatic activities. B200 treatment was found to reduce the intracellular JEV level observed by significant reduction in JEV-fluorescein isothiocyanate (FITC) expression in both neurons and microglia. Because microglia plays a crucial role in JEV pathogenesis, we further investigated the anti-JEV effects of B200 on human microglia cells and elucidated the mechanism of action by performing whole-transcriptome sequencing. Gene expression analysis revealed that B200 reduces the pro-apoptotic and inflammatory gene expression observed by significant reduction in BAD, BAX, CASP3, CASP8, IL1B, and CXCL10 and increase in IL10 responsive gene expression. Interestingly, our molecular docking analysis revealed that atropine and scopolamine interact with the His288 residue of NS3 protein, a crucial residue for RNA unwinding and ATPase activity that was further confirmed by degradation of NS3 protein. Drug likeness, ADME (absorption, distribution, metabolism, and excretion), and toxicity analysis further suggests that atropine and scopolamine both cross the blood-brain barrier, which is crucial for effective treatment of Japanese encephalitis (JE).